Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-23-8-5

Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with ADHD

Pediatric Neurology Briefs

Volume 23 (2009): Issue 8

By: J Gordon Millichap

Open Access

|Aug 2009

Abstract

The short-term and longer-term cardiovascular safety of high daily doses of OROS methylphenidate (MPH) of up to 1.5 mg/kg in 114 adolescents with ADHD is reported from Massachusetts General Hospital, Boston, MA.

References

Hammerness P Wilens T Mick E Spencer T Doyle R McCreary M Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder J Pediatr 2009 Jul 155 1 84 89.e1 10.1016/j.jpeds.2009.02.008 19394037
Open DOI Search in Google Scholar Back to article
Daniels SR Cardiovascular effects of methylphenidate J Pediatr 2009 Jul 155 1 A3 10.1016/j.jpeds.2009.05.023 19559283
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-23-8-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 61 - 61

Published on: Aug 1, 2009

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Cardiovascular,

Diastolic BP,

Methylphenidate

© 2009 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 23 (2009): Issue 8